Kyle RA. Multiple myeloma: review of 869 cases. Mayo Clin Proc. 1975;50:29–40.

CAS  PubMed  Google Scholar 

Sari I, Erkurt MA, Ifran A, Kaptan K, Beyan C. Multiple myeloma presenting with acquired factor VIII inhibitor. Int J Hematol. 2009;90:166–9.

Article  PubMed  Google Scholar 

Inano S, Oku Y, Aiba A, Kawasaki N, Okamoto Y, Yuhi N, et al. Acquired hypofibrinogenemia in a patient with multiple myeloma. Int J Hematol. 2021;114:395–400.

Article  CAS  PubMed  Google Scholar 

Hara Y, Makita M, Ishikawa T, Saeki K, Yamamoto K, Imajo K, et al. Lupus anticoagulant hypoprothrombinemia syndrome in Bence-Jones protein kappa-type multiple myeloma patient with phosphatidylserine-dependent antiprothrombin antibody. Ann Hematol. 2013;92:563–4.

Article  PubMed  Google Scholar 

Colwell NS, Tollefsen DM, Blinder MA. Identification of a monoclonal thrombin inhibitor associated with multiple myeloma and a severe bleeding disorder. Br J Haematol. 1997;97:219–26.

Article  CAS  PubMed  Google Scholar 

Robert F, Mignucci M, McCurdy SA, Maldonado N, Lee JY. Hemostatic abnormalities associated with monoclonal gammopathies. Am J Med Sci. 1993;306:359–66.

Article  CAS  PubMed  Google Scholar 

Martinez-Martinez I, Gonzalez-Porras JR, Cebeira MJ, de Arriba F, Espin S, Bohdan N, et al. Identification of a new potential mechanism responsible for severe bleeding in myeloma: immunoglobulins bind the heparin binding domain of antithrombin activating this endogenous anticoagulant. Haematologica. 2016;101:e423–6.

Article  PubMed  PubMed Central  Google Scholar 

Potgieter JJ, Damgaard M, Hillarp A. One-stage vs. chromogenic assays in haemophilia A. Eur J Haematol. 2015;94(Suppl 77):38–44.

Article  CAS  PubMed  Google Scholar 

Suzuki A, Suzuki N, Kanematsu T, Shinohara S, Arai N, Kikuchi R, et al. Performance evaluation of Revohem™ FVIII chromogenic and Revohem™ FIX chromogenic in the CS-5100 autoanalyser. Int J Lab Hematol. 2019;41:664–70.

Article  PubMed  Google Scholar 

Franchini M, Mannucci PM. Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice. Br J Clin Pharmacol. 2011;72:553–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tiede A, Werwitzke S, Scharf RE. Laboratory diagnosis of acquired hemophilia A: limitations, consequences, and challenges. Semin Thromb Hemost. 2014;40:803–11.

Article  CAS  PubMed  Google Scholar 

Kasper CK, Aledort L, Aronson D, Counts R, Edson JR, van Eys J, et al. Proceedings: a more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh. 1975;34:612.

CAS  PubMed  Google Scholar 

Ieko M, Naito S. Yoshida M [cross-mixing test to detect lupus anticoagulant for diagnosis of antiphospholipid syndrome]. Rinsho Byori. 2009;57:990–8.

CAS  PubMed  Google Scholar 

Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood. 1983;61:684–92.

Article  CAS  PubMed  Google Scholar 

Mulliez SM, De Keyser F, Verbist C, Vantilborgh A, Wijns W, Beukinga I, et al. Lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature. Lupus. 2015;24:736–45.

Article  CAS  PubMed  Google Scholar 

Mazodier K, Arnaud L, Mathian A, Costedoat-Chalumeau N, Haroche J, Frances C, et al. Lupus anticoagulant-hypoprothrombinemia syndrome: report of 8 cases and review of the literature. Medicine (Baltimore). 2012;91:251–60.

Article  PubMed  Google Scholar 

Henschen A, Lottspeich F, Kehl M, Southan C. Covalent structure of fibrinogen. Ann N Y Acad Sci. 1983;408:28–43.

Article  CAS  PubMed  Google Scholar 

Vu TT, Stafford AR, Leslie BA, Kim PY, Fredenburgh JC, Weitz JI. Batroxobin binds fibrin with higher affinity and promotes clot expansion to a greater extent than thrombin. J Biol Chem. 2013;288:16862–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gosselin RC, Adcock D, Hawes EM, Francart SJ, Grant RP, Moll S. Evaluating the use of commercial drug-specific calibrators for determining PT and APTT reagent sensitivity to dabigatran and rivaroxaban. Thromb Haemost. 2015;113:77–84.

Article  CAS  PubMed  Google Scholar 

Adcock DM, Gosselin R. Direct oral anticoagulants (DOACs) in the laboratory: 2015 review. Thromb Res. 2015;136:7–12.

Article  CAS  PubMed  Google Scholar 

Nawarawong W, Wyshock E, Meloni FJ, Weitz J, Schmaier AH. The rate of fibrinopeptide B release modulates the rate of clot formation: a study with an acquired inhibitor to fibrinopeptide B release. Br J Haematol. 1991;79:296–301.

Article  CAS  PubMed  Google Scholar 

Baglin TP, Langdown J, Frasson R, Huntington JA. Discovery and characterization of an antibody directed against exosite I of thrombin. J Thromb Haemost. 2016;14:137–42.

Article  CAS  PubMed  Google Scholar 

Perkins HA, MacKenzie MR, Fudenberg HH. Hemostatic defects in dysproteinemias. Blood. 1970;35:695–707.

Article  CAS  PubMed  Google Scholar 

Irsara C, Griesmacher A, Loacker L, Feistritzer C, Uberbacher CA, Amiral J. Anti-Thrombin IgA in a Patient with Multiple Myeloma Leading to In Vitro Interference in Multiple Coagulation Tests and Confounding Diagnosis. Hamostaseologie. 2024. https://doi.org/10.1055/a-2211-6841.

Article  PubMed  Google Scholar 

Wang J, Arroyo-Suarez R, Dasari S, Sekaran K, Tse W. Early versus late response to daratumumab-based triplet therapies in patients with multiple myeloma: a pooled analysis of trials POLLUX, CASTOR and MAIA. Leuk Lymphoma. 2022;63:1669–77.

Article  CAS  PubMed  Google Scholar